|
Mr. Pien is our President Chief Executive Officer and a member of the Board of Directors. Mr. Pien joined us on June 14 2007. Prior to joining us Mr. Pien was the Chairman and Chief Executive Officer and a Director of Chiron Corporation a biopharmaceutical company involved in three healthcare markets: blood testing vaccines and biopharmaceuticals from April 2003 until Chiron's merger with Novartis in April 2006. From April 2006 to June 2007 Mr. Pien performed consulting services. He joined Chiron from GlaxoSmithKline where he held roles in commercial operations and general management including positions as the head of the international business. Mr. Pien previously held key positions in SmithKline Beecham's pharmaceuticals business in the United States the United Kingdom and North Asia culminating in his tenure as President Pharmaceuticals-North America and head of the worldwide pharmaceutical and vaccines businesses. Prior to joining SmithKline Beecham he worked for six years for Abbott Laboratories and five years for Merck & Co. in positions of sales market research licensing and product management. Mr. Pien is a Massachusetts Institute of Technology graduate and received an M.B.A. from Carnegie-Mellon University. Mr. Pien currently serves as a director of ViroPharma Incorporated and Vanda Pharmaceuticals Inc. each a publicly traded biotechnology company. | 